William B. Stilley III - Aug 22, 2022 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Director
Signature
/s/ William B. Stilley, III
Stock symbol
ADIL
Transactions as of
Aug 22, 2022
Transactions value $
$0
Form type
4
Date filed
8/23/2022, 07:14 PM
Previous filing
Feb 25, 2022
Next filing
Jan 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Options Award $0 +100K $0.00 100K Aug 22, 2022 Common Stock 100K $0.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options to purchase 100,000 shares of the Company's common stock, vesting 50% after Purnovate, Inc. has held a pre-IND meeting with the FDA and the balance when the IND is granted.